The dengue virus envelope protein induced PAI-1 gene expression via MEK/ERK pathways

Thrombosis and Haemostasis

Volumn 104, Issue 6, 2010, Pages 1219-1227

  Shyu, Huey Wen ^a   Lin, Yi Ying ^a,b   Chen, Lien Cheng ^c   Wang, Yi Fen ^a   Yeh, Trai Ming ^d   Su, Shu Jem ^a   Cheng, Wei Cheng ^e   Chen, Chang Yu ^a   Lin, Kuan Hua ^a   Chou, Miao Chen ^a  

^a FOOYIN UNIVERSITY   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

^c Executive Yuan   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

Author keywords

Dengue virus type 2; Envelope glycoprotein domain III; Flaviviridae; Plasminogen activator inhibitor type 1

Indexed keywords

GLYCOPROTEIN E2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BLEEDING; DENGUE; DENGUE VIRUS; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

BLOOD COAGULATION; BLOTTING, WESTERN; BUTADIENES; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; NITRILES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; UP-REGULATION; VIRAL ENVELOPE PROTEINS;

EID: 78649725891     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-05-0302     Document Type: Article

References (68)

1. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10: 100-103.
2. Ahn JD, Morishita R, Kaneda Y, et al. Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells. Diabetologia 2001; 44: 713-720. (Pubitemid 32846026)
3. Chambers TJ, Liang Y, Droll DA, et al. Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model. J Virol 2003; 77: 3655-3668. (Pubitemid 36297285)
4. Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 2005; 3: 13-22. (Pubitemid 40028466)
5. Kuhn RJ, Zhang W, Rossmann MG, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002; 108: 717-725. (Pubitemid 34241430)
6. Preugschat F, Yao CW, Strauss JH. In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. J Virol 1990; 64: 4364-4374.
7. Gorbalenya AE, Donchenko AP, Koonin EV, et al. N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. Nucleic Acids Res 1989; 17: 3889-3897.
8. Chambers TJ, Grakoui A, Rice CM. Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J Virol 1991; 65: 6042-6050.
9. Falgout B, Pethel M, Zhang YM, et al. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 1991; 65: 2467-2475.
10. Yon C, Teramoto T, Mueller N, et al. Modulation of the nucleoside triphosphatase/RNA helicase and 5′-RNA triphosphatase activities of Dengue virus type 2 nonstructural protein 3 (NS3) by interaction with NS5, the RNA-dependent RNA polymerase. J Biol Chem 2005; 280: 27412-27419. (Pubitemid 41040783)
11. Roehrig JT, Bolin RA, Kelly RG. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 1998; 246: 317-328. (Pubitemid 28384045)
12. Crill WD, Roehrig JT. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 2001; 75: 7769-7773.
13. Rey FA. Dengue virus envelope glycoprotein structure: new insight into its interactions during viral entry. Proc Natl Acad Sci USA 2003; 100: 6899-6901.
14. Roehrig JT. Antigenic structure of flavivirus proteins. Adv Virus Res 2003; 59: 141-175.
15. Mandl CW, Allison SL, Holzmann H, et al. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol 2000; 74: 9601-9609.
16. Hung JJ, Hsieh MT, Young MJ, et al. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 2004; 78: 378-388.
17. Chin JF, Chu JJ, Ng ML. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes Infect 2007; 9: 1-6.
18. Binder BR, Mihaly J, Prager GW. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost 2007; 97: 336-342. (Pubitemid 46437793)
19. Vaughan DE. Plasminogen activator inhibitor-1: a common denominator in cardiovascular disease. J Investig Med 1998; 46: 370-376.
20. Hamsten A, Eriksson P. Fibrinolysis and atherosclerosis. Baillieres Clin Haematol 1995; 8: 345-363.
21. Nguyen TH, Lei HY, Nguyen TL, et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 2004; 189: 221-232.
22. Srikiatkhachorn A. Plasma leakage in dengue haemorrhagic fever. Thromb Haemost 2009; 102: 1042-1049.
23. Roncal C, Orbe J, Belzunce M, et al. The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin. J Thromb Haemost 2006; 4: 1798-1803. (Pubitemid 44144808)
24. Arndt A, Murphy P, Hart DA. Human HuH-7 hepatoma cells express urokinase and plasminogen activator inhibitor-1: identification, characterization and regulation by inflammatory mediators. Biochim Biophys Acta 1992; 1138: 149-156.
25. de Boer JP, Abbink JJ, Brouwer MC, et al. PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines - evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 1991; 65: 181-185.
26. Madoiwa S, Komatsu N, Mimuro J, et al. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation. Blood 1999; 94: 475-482. (Pubitemid 29323862)
27. Arts J, Grimbergen J, Toet K, et al. On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1alpha in HepG2 cells. Arterioscler Thromb Vasc Biol 1999; 19: 39-46. (Pubitemid 29031910)
28. Healy AM, Gelehrter TD. Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the acute phase response. J Biol Chem 1994; 269: 19095-19100.
29. Andrew AS, Klei LR, Barchowsky A. AP-1-dependent induction of plasminogen activator inhibitor-1 by nickel does not require reactive oxygen. Am J Physiol Lung Cell Mol Physiol 2001; 281: L616-623. (Pubitemid 32879214)
30. Kutz SM, Higgins CE, Samarakoon R, et al. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling. Exp Cell Res 2006; 312: 1093-1105.
31. Motojima M, Ando T, Yoshioka T. Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells. Biochem J 2000; 349: 435-441.
32. Wong C, Rougier-Chapman EM, Frederick JP, et al. Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol 1999; 19: 1821-1830.
33. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-157.
34. Olman MA, Hagood JS, Simmons WL, et al. Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element. Blood 1999; 94: 2029-2038.
35. Guo B, Inoki K, Isono M, et al. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells. Kidney Int 2005; 68: 972-984.
36. Vulin AI, Stanley FM. Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J Biol Chem 2004; 279: 25172-25178.
37. Lin JL, Chen HC, Fang HI, et al. MST4, a new Ste20-related kinase that mediates cell growth and transformation via modulating ERK pathway. Oncogene 2001; 20: 6559-6569.
38. Chen LC, Yeh TM, Lin YY, et al. The envelope glycoprotein domain III of dengue virus type 2 induced the expression of anticoagulant molecules in endothelial cells. Mol Cell Biochem 2010;
39. el-Roeiy A, Dmowski WP, Gleicher N, et al. Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis. Fertil Steril 1988; 50: 864-871.
40. Shyu HW, Hsu SH, Hsieh-Li HM, et al. Forced expression of RNF36 induces cell apoptosis. Exp Cell Res 2003; 287: 301-313.
41. Loskutoff DJ, Sawdey M, Keeton M, et al. Regulation of PAI-1 gene expression in vivo. Thromb Haemost 1993; 70: 135-137.
42. Wills BA, Oragui EE, Stephens AC, et al. Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. Clin Infect Dis 2002; 35: 277-285.
43. Van Gorp EC, Setiati TE, Mairuhu AT, et al. Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever. J Med Virol 2002; 67: 549-554.
44. Hageman J, Eggen BJ, Rozema T, et al. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene. Clin Cancer Res 2005; 11: 5956-5964.
45. Sakamoto T, Woodcock-Mitchell J, Marutsuka K, et al. TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes. Am J Physiol 1999; 276: C1391-1397.
46. Descheemaeker KA, Wyns S, Nelles L, et al. Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response. J Biol Chem 1992; 267: 15086-15091.
47. Arts J, Grimbergen J, Bosma PJ, et al. Role of c-Jun and proximal phorbol 12-myristate-13-acetate-(PMA)-responsive elements in the regulation of basal and PMA-stimulated plasminogen-activator inhibitor-1 gene expression in HepG2. Eur J Biochem 1996; 241: 393-402.
48. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40.
49. Perfettini JL, Castedo M, Roumier T, et al. Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ 2005; 12 (Suppl 1): 916-923.
50. Pasten C, Olave NC, Zhou L, et al. Polyphenols downregulate PAI-1 gene expression in cultured human coronary artery endothelial cells: molecular contributor to cardiovascular protection. Thromb Res 2007; 121: 59-65.
51. Hasan RN, Schafer AI. Hemin upregulates Egr-1 expression in vascular smooth muscle cells via reactive oxygen species ERK-1/2-Elk-1 and NF-kappaB. Circ Res 2008; 102: 42-50.
52. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180-186.
53. van Gorp EC, Suharti C, ten Cate H, et al. Review: infectious diseases and coagulation disorders. J Infect Dis 1999; 180: 176-186.
54. Sosothikul D, Seksarn P, Pongsewalak S, et al. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost 2007; 97: 627-634.
55. Huerta-Zepeda A, Cabello-Gutierrez C, Cime-Castillo J, et al. Crosstalk between coagulation and inflammation during Dengue virus infection. Thromb Haemost 2008; 99: 936-943.
56. Suharti C, van Gorp EC, Setiati TE, et al. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb Haemost 2002; 87: 42-46.
57. Schnittler HJ, Feldmann H. Viral hemorrhagic fever - a vascular disease? Thromb Haemost 2003; 89: 967-972.
58. Huang YH, Lei HY, Liu HS, et al. Tissue plasminogen activator induced by dengue virus infection of human endothelial cells. J Med Virol 2003; 70: 610-616.
59. Cabello-Gutierrez C, Manjarrez-Zavala ME, Huerta-Zepeda A, et al. Modification of the cytoprotective protein C pathway during Dengue virus infection of human endothelial vascular cells. Thromb Haemost 2009; 101: 916-928.
60. Dimova EY, Kietzmann T. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Thromb Haemost 2008; 100: 992-1006.
61. Dai J, Huang C, Wu J, et al. Iron-induced interleukin-6 gene expression: possible mediation through the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. Toxicology 2004; 203: 199-209.
62. Roger T, Bresser P, Snoek M, et al. Exaggerated IL-8 and IL-6 responses to TNFalpha by parainfluenza virus type 4-infected NCI-H292 cells. Am J Physiol Lung Cell Mol Physiol 2004; 287: L1048-1055.
63. Dragon S, Rahman MS, Yang J, et al. IL-17 enhances IL-1beta-mediated CXCL-8 release from human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1023-1029.
64. Sadowska B, Barrucco R, Khalili K, et al. Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J Virol 2003; 77: 665-672. (Pubitemid 36005003)
65. Kohno M, Pouyssegur J. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog Cell Cycle Res 2003; 5: 219-224.
66. Medin CL, Rothman AL. Cell type-specific mechanisms of interleukin-8 induction by dengue virus and differential response to drug treatment. J Infect Dis 2006; 193: 1070-1077.
67. Matsuda T, Almasan A, Tomita M, et al. Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. J Gen Virol 2005; 86: 1055-1065.
68. Monroy V, Ruiz BH. Participation of the Dengue virus in the fibrinolytic process. Virus Genes 2000; 21: 197-208.